Opus Genetics IRD
NASDAQ IRD
$4.58 +0.07 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Opus Genetics (IRD) reported Return on Capital Employed [ROCE] of -70.02% for Q2 2026, up 209.31 percentage points from -279.34% a year earlier and up 17.49 percentage points from the prior quarter.

Analysis

Opus Genetics (IRD) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Opus Genetics posted Return on Capital Employed [ROCE] of -107.90%, up 74.08 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +197.04 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -181.98% in FY2024 (-159.71 pp), -22.27% in FY2023 (-74.67 pp), 52.40% in FY2022 (+178.37 pp) and -125.97% in FY2021 (+178.98 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q2 2024.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of -129.36 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2026 (a gain of 264.53 percentage points); the low point was Q3 2025 (a drop of 703.93 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -87.51% (Q1 2026), -109.03% (Q4 2025) and -784.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Opus Genetics 372.74 Mn 148.02 Mn - -70.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -70.02%
Mar 31, 2026 -87.51%
Dec 31, 2025 -109.03%
Sep 30, 2025 -784.63%
Jun 30, 2025 -279.34%
Mar 31, 2025 -352.04%
Dec 31, 2024 -227.12%
Sep 30, 2024 -80.70%
Jun 30, 2024 -34.16%
Mar 31, 2024 -25.77%
Dec 31, 2023 -21.11%
Sep 30, 2023 64.73%
Jun 30, 2023 46.94%
Mar 31, 2023 43.22%
Dec 31, 2022 62.79%
Sep 30, 2022 -163.44%
Jun 30, 2022 -137.39%
Mar 31, 2022 -119.73%
Dec 31, 2021 -109.23%
Sep 30, 2021 -141.63%
API Access

Opus Genetics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IRD&period=max&api_key=YOUR_API_KEY